International Roadshow: New Advances in Endocrinology and Metabolic Diseases

Journal article

C. Steenblock, M. Saber-Ayad, S. Bornstein
Hormone and Metabolic Research, 2024

Cite

APA Click to copy
Steenblock, C., Saber-Ayad, M., & Bornstein, S. (2024). International Roadshow: New Advances in Endocrinology and Metabolic Diseases. Hormone and Metabolic Research.

Chicago/Turabian Click to copy
Steenblock, C., M. Saber-Ayad, and S. Bornstein. “International Roadshow: New Advances in Endocrinology and Metabolic Diseases.” Hormone and Metabolic Research (2024).

MLA Click to copy
Steenblock, C., et al. “International Roadshow: New Advances in Endocrinology and Metabolic Diseases.” Hormone and Metabolic Research, 2024.

BibTeX Click to copy

@article{c2024a,
  title = {International Roadshow: New Advances in Endocrinology and Metabolic Diseases},
  year = {2024},
  journal = {Hormone and Metabolic Research},
  author = {Steenblock, C. and Saber-Ayad, M. and Bornstein, S.}
}

Abstract

Dear Readers, Currently, there is a myriad of new developments in the field of endocrinology. In particular, significant strides have been made in the development of poly-agonists for the treatment of type 2 diabetes and obesity 1 2 . Poly-agonists represent a novel therapeutic approach by combining multiple actions within a single molecule, targeting multiple receptors simultaneously to achieve enhanced efficacy. These innovative compounds aim to address the complex interplay of hormonal pathways involved in glucose regulation and metabolism, offering potential breakthroughs in the management of diabetes and obesity.